JUVE Patent
About Erich Fritsche
About Dr. Erich Fritsche
Dr. Erich Fritsche is a Patent Attorney and partner of the firm. As a biochemist with a doctorate, he specializes in the technical fields of chemistry, pharmacy, and biology/biotechnology. Dr. Fritsche has been working as a Patent Attorney for more than 20 years and advises domestic and foreign clients in all matters of patent law.
Dr. Fritsche advises start-ups and medium-sized companies, as well as large international corporations on all issues of patent and utility model law. The focus of his work is on obtaining, defending, and enforcing patents in the fields of chemistry, pharmaceuticals, biology, and biotechnology. He regularly represents clients in opposition and appeal proceedings before the European Patent Office and has achieved important successes for his clients in numerous proceedings. Dr. Fritsche is admitted as representative at the UPC (European Patent Litigator (UPC)) since June 2023.
In addition, Dr. Erich Fritsche has extensive experience in managing complex patent portfolios, preparing freedom-to-operate, validity and infringement opinions, conducting due diligence analyses, and representing and participating in nullity and infringement proceedings.
Fields of law
Patent law
Sectors
Green Technologies
Chemicals
Pharmaceuticals
Biotechnology
Erich Fritsche
WALLINGER RICKER SCHLOTTER TOSTMANN
Zweibrückenstraße 5-7
80331 Munich
Germany
+49892102320
efritsche@wallinger.com
4 Specialisms
- Biotechnology
- Chemistry
- Food Chemistry
- Pharmaceuticals
Awards
- Recognized in The Best Lawyers in Germany™ 2025 for work in Intellectual Property Law
Publications
- "Plausibility as a hurdle for patenting", by Dr. Erich Fritsche and Dr. Cornelia Oetke, in: |transkript Special "Financing + BIO-Europe", issue 11-12, 2018
- "Process patents - a sharp sword!?", IP commentary, by Dr. Erich Fritsche, in: |transkript, issue 5, 2018
- "Patents on Plants and Animals: Quo Vadis EPO?", by Dr. Erich Fritsche, in: AIPLA American Intellectual Property Law Association, Biotech Buzz, 2018
- "Patents on Plants & Animals: Quo vadis EPO?", by Dr. Erich Fritsche, in: |transcript, issue 9, 2017
- "What is the unitary patent?", patent commentary, by Dr. Erich Fritsche and Dr. Laura Leitner, in: |transkript, issue 1-2, 2018
- "The healthcare of the future is individual," by Dr. Erich Fritsche and Dr. Mathias Ricker, in: Science4Life, annual brochure, 2015
- "The EU unitary patent: curse or blessing?", by Dr. Erich Fritsche and Dr. Mathias Ricker, in: GoingPublic Magazine - Special "Biotechnology 2013", 2013
- "Innovative power: patents and medical technology", by Dr. Erich Fritsche and Dr. Mathias Ricker, in: GoingPublic Magazin, issue 11, 2013
- H.J. Schramm, J. Boetzel, J. Büttner, E. Fritsche, W. Göhring, E. Jaeger, S. König, O. Thumfart, T. Wenger, N.E. Nagel und W. Schramm, The inhibition of human immunodeficiency virus proteases by ‘interface peptides’, Antiviral Research 30:155-170, 1996
- A. Humm, E. Fritsche und S. Steinbacher, Structure and reaction mechanism of L-arginine:glycine amidinotransferase, Biol. Chem. 378:193-197, 1997
- A. Humm, E. Fritsche, K. Mann, M. Göhl und R. Huber, Recombinant expression and isolation of human L-arginine:glycine amidinotransferase and identification of its active-site cysteine residue, Biochem. J. 322:771-776, 1997
- E. Fritsche, A. Humm und R. Huber, Substrate binding and catalysis by L-arginine:glycine amidinotransferase, A mutagenesis and crystallographic study, Eur. J. Biochem. 247:483-490, 1997
- A. Humm, E. Fritsche, S. Steinbacher und R. Huber, Crystal structure and mechanism of human L-arginine:glycine amidinotransferase: a mitochondrial enzyme involved in creatine biosynthesis, EMBO J. 16:3373-3385, 1997
- E. Fritsche, A. Bergner, A. Humm, W. Piepersberg und R. Huber,Crystal structure of L-arginine:inosamine-phosphate amidinotransferase StrB1 from Streptomyces griseus: an enzyme involved in streptomycin biosynthesis, Biochemistry 37:17664-17672, 1998
- E. Fritsche, A. Paschos, H.-G. Beisel, A. Böck und R. Huber, Crystal structure of the hydrogenase maturating endopeptidase HYBD from Escherichia coli, J. Mol. Biol. 288:989-998, 1999
- E. Fritsche, A. Humm und R. Huber, The ligand-induced structural changes of human L-arginine:glycine amidinotransferase: a mutational and crystallographic study, J. Biol. Chem. 274:3026-3032, 1999
- E. Theodoratou, A. Paschos, A. Magalon, E. Fritsche, R. Huber und A. Böck, Nickel serves as a substrate recognition motif for the endopeptidase involved in hydrogenase maturation, Eur. J. Biochem. 267:1995-1999, 2000
- A. Paschos, E. Theodoratou, E. Fritsche, A. Böck und R. Huber, Hydrogenase maturation endopeptidase, in: Handbook of Proteolytic Enzymes (2. Aufl.), 980-982, 2004
